Johnson & Johnson professional education and development manager, David Jameson, discusses the current options in a practitioners’ armory when an astigmatic contact lens patient presents with presbyop ...
Tenpoint Therapeutics is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, Orasis Pharma, and LENZ Therapeutics, after getting FDA approval for its ...
The Punch on MSN
FG expands eye care initiative to eight states
The Federal Government, through the JigiBola 2.0 Initiative, on Wednesday announced the expansion of the programme to eight additional states.The beneficiary states are Edo, Enugu, Nasarawa, Ogun, ...
Methods: A population-based cross-sectional study was performed to evaluate the prevalence and related factors of presbyopia among urban and rural adults over 50 years in more than 50 communities of ...
Vishal Gohil, professional education and development manager at Alcon, shares advice and tips to reduce contact lens dropouts in presbyopia Dropout among presbyopic patients often stems from two key ...
Eye care professionals tell Andrew McCarthy-McClean how they prepare patients for presbyopia In 2026, the UK population is projected to reach 70 million. There were around 12.7m people aged 65 and ...
The most common side effects were headache, impaired vision, and temporary eye pain or eye irritation. "The FDA approval of Yuvezzi represents a significant milestone for the millions of people in the ...
The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore age-related near-sightedness, without the need for surgery, for a longer ...
Yuvezzi is expected to be available in the second quarter of 2026. The Food and Drug Administration (FDA) has approved Yuvezzi ™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% for ...
Eye redness was not a commonly reported side effect in clinical trials of YUVEZZI. In BRIO I and BRIO II the reports of adverse events of ocular hyperemia (eye redness) were low. 1,2 In BRIO II, the ...
LONDON & SEATTLE--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today ...
I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results